Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABCA1 and atherosclerosis.

S Soumian1, C Albrecht, A H Davies

  • 1Department of Vascular Surgery, Faculty of Medicine, Imperial College, Charing Cross Hospital, London, UK. s.soumian@imperial.ac.uk

Vascular Medicine (London, England)
|July 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orai1 mediates I<sub>CRAC</sub> and SOCE in human placental extravillous trophoblasts and contributes to cell viability, migration, and invasion.

Cell calcium·2026
Same author

Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025
Same author

The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2024
Same author

Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trial.

BMJ open·2024
Same author

Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2024
Same author

Study protocol for neuromuscular stimulation for rehabilitation after general and vascular surgery: a pilot randomised clinical study.

BMJ open·2023
Same journal

Images in Vascular Medicine: When coronary anatomy goes the wrong way-A diagnostic challenge.

Vascular medicine (London, England)·2026
Same journal

Home-based intravenous iloprost by portable elastomeric pump in chronic limb-threatening ischemia: A pilot study.

Vascular medicine (London, England)·2026
Same journal

Vascular Disease Patient Information Page: Renal denervation.

Vascular medicine (London, England)·2026
Same journal

Relations of Life's Essential 8 score with arterial and microvascular function: The Jackson Heart Study.

Vascular medicine (London, England)·2026
Same journal

Generalizability of the CREST‑2 trial: A real‑world analysis.

Vascular medicine (London, England)·2026
Same journal

Downhill-walking exercise training in a patient with symptomatic peripheral artery disease: A case report.

Vascular medicine (London, England)·2026
See all related articles

ATP binding cassette transporter A1 (ABCA1) is crucial for cholesterol efflux and HDL metabolism. Its dysfunction contributes to atherosclerosis, but therapeutic targeting via PPAR and LXR agonists shows promise for managing this disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • ATP binding cassette transporter A1 (ABCA1) is key in cellular cholesterol and phospholipid efflux to apolipoprotein A1 (apoA1), impacting high-density lipoprotein (HDL) metabolism.
  • ABCA1 dysfunction causes Tangier disease, linking it to atherosclerosis, a process involving lipid regulation, apoptosis, and inflammation.

Purpose of the Study:

  • To review the role of ABCA1, liver-X-receptor-alpha (LXRalpha), and peroxisome proliferator-activated receptor-gamma (PPARgamma) in atherosclerosis.
  • To explore the therapeutic potential of targeting the PPAR-LXR-ABCA1 pathway for managing atherosclerotic progression.

Main Methods:

  • A Medline-based literature review was conducted.
  • Analysis of evidence from Tangier disease, human heterozygotes with ABCA1 mutations, and in vitro/animal studies.

Related Experiment Videos

Main Results:

  • ABCA1 is a major factor influencing atherosclerosis, mediating cholesterol efflux and regulating apoptosis and inflammation.
  • PPAR-LXR-ABCA1 interactions are vital for cholesterol homeostasis, with these receptors exhibiting anti-inflammatory properties.
  • The plaque microenvironment may negatively impact ABCA1 function, compromising cholesterol efflux.

Conclusions:

  • ABCA1 plays a critical role in cholesterol homeostasis and atherosclerosis.
  • Therapeutic strategies involving PPAR and LXR agonists, alongside ABCA1 stabilization, offer potential for modifying atherosclerotic lesion progression.